These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22469921)

  • 1. Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells.
    Li J; Liang S; Jin H; Xu C; Ma D; Lu X
    Oncol Rep; 2012 Jun; 27(6):1835-42. PubMed ID: 22469921
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potential role of ezrin and its related microRNA in ovarian cancer invasion and metastasis].
    Li J; Liang SH; Lu X
    Zhonghua Fu Chan Ke Za Zhi; 2010 Oct; 45(10):787-92. PubMed ID: 21176563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thyroid hormone regulation of miR-21 enhances migration and invasion of hepatoma.
    Huang YH; Lin YH; Chi HC; Liao CH; Liao CJ; Wu SM; Chen CY; Tseng YH; Tsai CY; Lin SY; Hung YT; Wang CJ; Lin CD; Lin KH
    Cancer Res; 2013 Apr; 73(8):2505-17. PubMed ID: 23442323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Screening and identification of potential miRNA involved in ovarian cancer invasion and metastasis].
    Liang SH; Li J; Al-beit M; Zhang J; Ma D; Lu X
    Zhonghua Zhong Liu Za Zhi; 2010 Sep; 32(9):650-4. PubMed ID: 21122376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-9 inhibits ovarian cancer cell growth through regulation of NF-kappaB1.
    Guo LM; Pu Y; Han Z; Liu T; Li YX; Liu M; Li X; Tang H
    FEBS J; 2009 Oct; 276(19):5537-46. PubMed ID: 19702828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. miR-335 represents an invasion suppressor gene in ovarian cancer by targeting Bcl-w.
    Cao J; Cai J; Huang D; Han Q; Yang Q; Li T; Ding H; Wang Z
    Oncol Rep; 2013 Aug; 30(2):701-6. PubMed ID: 23708561
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An inhibitory effect of miR-22 on cell migration and invasion in ovarian cancer.
    Li J; Liang S; Yu H; Zhang J; Ma D; Lu X
    Gynecol Oncol; 2010 Dec; 119(3):543-8. PubMed ID: 20869762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNA-22 suppresses colon cancer cell migration and invasion by inhibiting the expression of T-cell lymphoma invasion and metastasis 1 and matrix metalloproteinases 2 and 9.
    Li B; Song Y; Liu TJ; Cui YB; Jiang Y; Xie ZS; Xie SL
    Oncol Rep; 2013 May; 29(5):1932-8. PubMed ID: 23440286
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic silencing of miR-130b in ovarian cancer promotes the development of multidrug resistance by targeting colony-stimulating factor 1.
    Yang C; Cai J; Wang Q; Tang H; Cao J; Wu L; Wang Z
    Gynecol Oncol; 2012 Feb; 124(2):325-34. PubMed ID: 22005523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MiR-145 is downregulated in human ovarian cancer and modulates cell growth and invasion by targeting p70S6K1 and MUC1.
    Wu H; Xiao Z; Wang K; Liu W; Hao Q
    Biochem Biophys Res Commun; 2013 Nov; 441(4):693-700. PubMed ID: 24157791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Actin-related protein 2/3 complex subunit 5 (ARPC5) contributes to cell migration and invasion and is directly regulated by tumor-suppressive microRNA-133a in head and neck squamous cell carcinoma.
    Kinoshita T; Nohata N; Watanabe-Takano H; Yoshino H; Hidaka H; Fujimura L; Fuse M; Yamasaki T; Enokida H; Nakagawa M; Hanazawa T; Okamoto Y; Seki N
    Int J Oncol; 2012 Jun; 40(6):1770-8. PubMed ID: 22378351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. By downregulating TIAM1 expression, microRNA-329 suppresses gastric cancer invasion and growth.
    Li Z; Yu X; Wang Y; Shen J; Wu WK; Liang J; Feng F
    Oncotarget; 2015 Jul; 6(19):17559-69. PubMed ID: 25654811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of HOXD10 expression induced by upregulation of miR-10b accelerates the migration and invasion activities of ovarian cancer cells.
    Nakayama I; Shibazaki M; Yashima-Abo A; Miura F; Sugiyama T; Masuda T; Maesawa C
    Int J Oncol; 2013 Jul; 43(1):63-71. PubMed ID: 23670532
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of T-lymphoma and metastasis gene 1 in gastric cancer and its involvement in cell invasion and migration.
    Shi YL; Miao RZ; Cheng L; Guo XB; Yang B; Jing CQ; Zhang L; Jin X; Li LP
    Chin Med J (Engl); 2013 Feb; 126(4):640-5. PubMed ID: 23422181
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1 inhibits ovarian cancer cell proliferation and migration through c-Met pathway.
    Qu W; Chen X; Wang J; Lv J; Yan D
    Clin Chim Acta; 2017 Oct; 473():237-244. PubMed ID: 28698064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of ovarian cancer progression by microRNA-187 through targeting Disabled homolog-2.
    Chao A; Lin CY; Lee YS; Tsai CL; Wei PC; Hsueh S; Wu TI; Tsai CN; Wang CJ; Chao AS; Wang TH; Lai CH
    Oncogene; 2012 Feb; 31(6):764-75. PubMed ID: 21725366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-182 promotes cell growth, invasion, and chemoresistance by targeting programmed cell death 4 (PDCD4) in human ovarian carcinomas.
    Wang YQ; Guo RD; Guo RM; Sheng W; Yin LR
    J Cell Biochem; 2013 Jul; 114(7):1464-73. PubMed ID: 23296900
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells.
    Li Z; Hu S; Wang J; Cai J; Xiao L; Yu L; Wang Z
    Gynecol Oncol; 2010 Oct; 119(1):125-30. PubMed ID: 20624637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Silencing of ZNF217 gene influences the biological behavior of a human ovarian cancer cell line.
    Sun G; Zhou J; Yin A; Ding Y; Zhong M
    Int J Oncol; 2008 May; 32(5):1065-71. PubMed ID: 18425333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.